Transcutaneous lisuride therapy of Parkinson's disease

Trial Profile

Transcutaneous lisuride therapy of Parkinson's disease

Completed
Phase of Trial: Phase II

Latest Information Update: 31 Jan 2017

At a glance

  • Drugs Lisuride (Primary)
  • Indications Parkinson's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Jun 2008 Axxonis submitted MAA to EMEA for transdermal lisuride as add-on therapy for Parkinson's Disease and Restless Legs Syndrome.
    • 25 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top